Table 2.
Baseline characteristics of the uveitis patient at the time of diagnosis
| Number (%) | |
|---|---|
| Patient level baseline characteristics | |
| Number of patients (n) | 491 |
| Female gender | 278 (56.6) |
| Mean age (SD), years | 45.5 (21.5) |
| Race | |
| Asian | 5 (1.0) |
| African American | 134 (27.3) |
| Caucasian | 298 (60.7) |
| Hispanic | 12 (2.4) |
| Other | 42 (8.5) |
| Systemic involvement | 335 (68.2) |
| Bilateral vision reported (n=491) | 153 (31.2) |
| Vision loss (n=481) | |
| MdVL (logMAR: <0.4) | 280 (58.2) |
| MVL (logMAR: [0.4–1]) | 85 (17.7) |
| SVL (logMAR: ≥1) | 116 (24.1) |
| Eye level baseline characteristics | |
| Number of eyes (ne) | 644 |
| Non-anterior uveitis | 237 (36.8) |
| Median length of follow-up (interquartile range) years, (ne =520) | 4.8 (0.2–6.8) |
| Mean BCVA (SD), logMAR (ne =633) | 0.52 (0.74) |
| Visions loss (ne =633) | |
| MdVL (logMAR: <0.4) | 415 (65.6) |
| MVL (logMAR: [0.4–1]) | 64 (10.1) |
| SVL (logMAR: ≥1) | 154 (24.3) |
| Mean BCVA overall (SD), logMAR (ne =633) | 0.52 (0.74) |
| MdVL, mean BCVA (SD) | 0.13 (0.13) |
| MVL, mean BCVA (SD) | 0.56 (0.06) |
| SVL, mean BCVA (SD) | 1.56 (0.86) |
Abbreviations: BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; SD, the standard deviation of the measurement distribution; MdVL, mild visual loss; MVL, moderate visual loss; SVL, severe visual loss; ne, number of eyes.